MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH Purchases 7,391 Shares of HCA Healthcare, Inc. (NYSE:HCA)

MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH boosted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 2,471.9% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,690 shares of the company’s stock after purchasing an additional 7,391 shares during the period. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH’s holdings in HCA Healthcare were worth $2,565,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in the stock. Financial Strategies Group Inc. boosted its stake in shares of HCA Healthcare by 12.8% in the first quarter. Financial Strategies Group Inc. now owns 16,289 shares of the company’s stock valued at $5,357,000 after buying an additional 1,844 shares during the period. Aviance Capital Partners LLC bought a new stake in HCA Healthcare during the first quarter worth $2,543,000. LVW Advisors LLC lifted its stake in HCA Healthcare by 76.4% during the first quarter. LVW Advisors LLC now owns 3,189 shares of the company’s stock worth $1,064,000 after purchasing an additional 1,381 shares during the last quarter. Red Door Wealth Management LLC lifted its stake in HCA Healthcare by 4.6% during the first quarter. Red Door Wealth Management LLC now owns 19,868 shares of the company’s stock worth $6,627,000 after purchasing an additional 881 shares during the last quarter. Finally, New Mexico Educational Retirement Board lifted its stake in HCA Healthcare by 29.9% during the first quarter. New Mexico Educational Retirement Board now owns 13,900 shares of the company’s stock worth $4,636,000 after purchasing an additional 3,200 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $319.70 on Wednesday. The company has a current ratio of 1.16, a quick ratio of 1.02 and a debt-to-equity ratio of 29.26. The business has a 50-day moving average price of $326.06 and a two-hundred day moving average price of $317.80. The company has a market cap of $83.73 billion, a P/E ratio of 15.94, a PEG ratio of 1.49 and a beta of 1.68. HCA Healthcare, Inc. has a 1-year low of $215.96 and a 1-year high of $344.20.

HCA Healthcare (NYSE:HCAGet Free Report) last issued its earnings results on Friday, April 26th. The company reported $5.36 EPS for the quarter, beating the consensus estimate of $5.01 by $0.35. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. The company had revenue of $17.34 billion during the quarter, compared to the consensus estimate of $16.81 billion. During the same period last year, the business posted $4.93 EPS. The firm’s revenue for the quarter was up 11.2% compared to the same quarter last year. As a group, analysts anticipate that HCA Healthcare, Inc. will post 20.92 EPS for the current year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, June 28th. Investors of record on Friday, June 14th were given a $0.66 dividend. The ex-dividend date of this dividend was Friday, June 14th. This represents a $2.64 annualized dividend and a yield of 0.83%. HCA Healthcare’s payout ratio is 13.16%.

Insider Transactions at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 1,600 shares of the business’s stock in a transaction that occurred on Monday, May 6th. The stock was sold at an average price of $309.00, for a total value of $494,400.00. Following the transaction, the executive vice president now owns 34,124 shares in the company, valued at approximately $10,544,316. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In related news, EVP Michael S. Cuffe sold 1,600 shares of the company’s stock in a transaction that occurred on Monday, May 6th. The stock was sold at an average price of $309.00, for a total value of $494,400.00. Following the transaction, the executive vice president now owns 34,124 shares in the company, valued at $10,544,316. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Michael S. Cuffe sold 6,311 shares of the company’s stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $316.88, for a total value of $1,999,829.68. Following the completion of the transaction, the executive vice president now owns 29,624 shares in the company, valued at approximately $9,387,253.12. The disclosure for this sale can be found here. Insiders have sold 12,397 shares of company stock worth $3,921,929 in the last 90 days. Insiders own 1.70% of the company’s stock.

Analysts Set New Price Targets

HCA has been the subject of several recent analyst reports. Oppenheimer upped their target price on HCA Healthcare from $330.00 to $345.00 and gave the stock an “outperform” rating in a research note on Monday, April 29th. Wells Fargo & Company increased their price target on HCA Healthcare from $303.00 to $315.00 and gave the company an “equal weight” rating in a research note on Thursday, March 28th. Robert W. Baird assumed coverage on HCA Healthcare in a research note on Thursday, May 30th. They issued an “outperform” rating and a $396.00 price target for the company. Deutsche Bank Aktiengesellschaft increased their price target on HCA Healthcare from $359.00 to $375.00 and gave the company a “buy” rating in a research note on Friday, June 28th. Finally, TD Cowen decreased their price objective on HCA Healthcare from $371.00 to $360.00 and set a “buy” rating for the company in a report on Tuesday, April 30th. Four analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $326.53.

Read Our Latest Analysis on HCA Healthcare

About HCA Healthcare

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Read More

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.